Tata Chemicals logo

Tata Chemicals

TATACHEM NSE

Key Fundamentals

SmallcapCommodity ChemicalsChemicals
Market Cap
₹15,419 Cr
Volatility
Moderate
P/E Ratio
-7.9
EBITDA
₹2,121 Cr
Return on Equity
-7.73%
Debt to Equity
0.38
Book Value
₹832.38
EPS
₹29.55
52W High
₹1,026.65
52W Low
₹580.3

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Stock is trading at 0.74 times its book value
  • Company has been maintaining a healthy dividend payout of 82.4%

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.41% over past five years.
  • Company has a low return on equity of 1.59% over last 3 years.

Growth Rate

Revenue Growth
-1.4% higher than 3Y
Net Income Growth
-584% lower than 3Y
Cash Flow Change
-27.94% higher than 3Y
ROE
-592% lower than 3Y
ROCE
-178% lower than 3Y
EBITDA Margin (Avg.)
-1.25% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk high

Tata Chemicals Ltd trades at a market cap of ₹15,518 Cr with a price-to-book ratio of 0.74x, indicating the stock is available below its book value. However, the company reported a negative PE of -7.9x reflecting recent losses, with compounded profit declining 51% over 3 years and TTM profit growth at -193%, signaling a sharp earnings deterioration in the current cycle.

Bull Case 7
  • Stock trades at 0.74x book value, a significant discount to its net asset base, which may offer a margin of safety for value-oriented investors
  • Company maintains a healthy dividend payout ratio of 82.4% with a current dividend yield of 1.79%, providing income even during a downturn in earnings
  • Over a 10-year period, the stock has delivered a CAGR of 9%, demonstrating long-term wealth creation despite near-term headwinds
  • 5-year compounded sales growth stands at 7%, indicating the company has been able to grow its top line over the medium term
  • 5-year compounded profit growth remains positive at 3%, suggesting the current earnings decline may be cyclical rather than structural
  • 10-year ROE averages 10%, reflecting that the business has historically been capable of generating reasonable returns on shareholder equity
  • TTM sales growth of 2% shows revenue has stabilized and is not contracting, even as profitability has come under pressure
Bear Case 8
  • Negative PE ratio of -7.9x indicates the company is currently loss-making, a serious concern for earnings visibility
  • TTM compounded profit growth of -193% reflects a dramatic swing from profit to loss in the most recent period
  • 3-year compounded profit CAGR of -51% shows a sustained and deep erosion in profitability, not a one-off event
  • Last year ROE of just 1% and 3-year average ROE of 2% indicate very poor capital efficiency in the recent period
  • Low interest coverage ratio flags potential stress in servicing debt obligations from operating earnings
  • 3-year compounded sales growth is negative at -5%, indicating the top line has actually shrunk over this period
  • Stock price CAGR of -35% over 1 year and -17% over 3 years reflects significant value destruction for shareholders
  • 10-year compounded sales growth of 0% suggests the company has struggled to grow revenue meaningfully over the long term

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Headwinds 4
  • Kenya ops revoked by President Sep 3

    President Ruto ordered Tata Chemicals Magadi to exit Kenya, revoking a century-old soda ash concession. TCML contributes ~3.8% of consolidated revenue (₹586 crore) and ~6% of EBITDA, with 350,000 tonnes annual capacity and ~500 jobs at risk.

  • ₹586 Cr regulatory storm deepens Sep 4

    Kenya's mining suspension (July 28) cited unpaid royalties, weak local procurement, and lapsed mining licence. TCML's High Court challenge failed on Aug 7, and a separate ₹890 crore land-rates dispute with Kajiado county is before Kenya's Supreme Court.

  • Q1 FY27 net loss of ₹17 Cr Aug 29

    Tata Chemicals reported a consolidated net loss of ₹17 crore in Q1 FY27 vs net profit of ₹525 crore a year ago. Stock has fallen 33% over the past year and 11% in six months.

  • African sovereign risk escalation Sep 4

    Ruto's April 2026 ban on raw mineral exports signals broader resource nationalism across Africa, raising sovereign risk for Indian multinationals including Tata Group, Reliance, and Adani with Kenyan operations.

Positives 2
  • SVM soda ash contracts acquired Aug 29

    TCNA acquired 500,000+ MT of North American soda ash customer contracts from bankrupt Searles Valley Minerals for $21.16 million, expecting over $110 million in revenue through December 2028 with zero capex on asset creation.

  • Mithapur ecosystem rated healthy Sep 1

    A CSIR-CSMCRI study confirmed the coastal ecosystem around Tata Chemicals' Mithapur plant is healthy and biodiverse, with stable water quality and rich avifauna following wastewater pipeline transition.

Neutral 3
  • Kenya compliance docs submitted Sep 4

    Tata Chemicals confirmed TCML submitted all required compliance documentation on Aug 11 and is awaiting the Kenyan Ministry's review, asserting full regulatory compliance while remaining open to constructive engagement.

  • Technical committee for mining formed Sep 9

    Tata Chemicals formed a technical committee co-led by the Principal Secretary for Mining and TCML CEO, signalling structured government-corporate engagement on the Kenya situation.

  • ESG score of 59 disclosed Sep 3

    Tata Chemicals disclosed an NSE Sustainability ESG score of 59 for FY26, assigned independently based on public data.

TL;DR: Tata Chemicals faces a significant geopolitical headwind as Kenya revokes its century-old Magadi soda ash concession, threatening ~3.8% of consolidated revenue and high-margin African operations. The Q1 FY27 net loss of ₹17 crore and 33% stock decline over the past year compound investor concerns. On the positive side, the $21.16 million SVM contract acquisition secures 500,000+ MT of North American soda ash demand through 2028 with zero capex. The trend is deteriorating near-term as Kenya legal proceedings and potential forced exit dominate the outlook, though the financial impact appears manageable if the company successfully redeploys capital.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,218
3,998
3,730
3,475
3,789
3,999
3,590
3,509
3,719
3,877
3,550
3,438
4,255
Expenses
3,175
3,191
3,188
3,032
3,215
3,381
3,156
3,182
3,070
3,340
3,205
3,164
3,717
Operating Profit
1,043
807
542
443
574
618
434
327
649
537
345
274
538
OPM %
25%
20%
15%
13%
15%
15%
12%
9%
17%
14%
10%
8%
13%
Other Income
67
187
98
-861
116
152
-10
29
138
128
21
-1,760
56
Interest
123
145
132
130
133
145
148
137
147
144
146
153
148
Depreciation
229
234
246
271
273
277
280
293
280
285
293
343
336
PBT
758
615
262
-819
284
348
-4
-74
360
236
-73
-1,982
110
Tax %
23%
20%
26%
3%
33%
23%
425%
-34%
12%
35%
-5%
7%
45%
Net Profit
587
495
194
-841
190
267
-21
-49
316
154
-69
-2,116
60
EPS in Rs
20.88
16.8
6.2
-33.36
5.89
7.61
-2.08
-2.2
9.89
3.02
-3.65
-83.67
-0.67
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17,204
14,873
10,346
10,270
10,337
10,357
10,200
12,622
16,789
15,421
14,887
14,584
15,120
Expenses
15,305
12,777
8,249
6,926
8,538
8,411
8,693
10,303
12,969
12,574
12,934
12,779
13,426
Operating Profit
1,900
2,096
2,097
3,344
1,799
1,945
1,506
2,319
3,820
2,847
1,953
1,805
1,694
OPM %
11%
14%
20%
33%
17%
19%
15%
18%
23%
18%
13%
12%
11%
Other Income
183
210
293
262
785
6,480
254
472
218
-507
287
-1,473
-1,555
Interest
461
525
297
326
354
342
367
303
406
530
563
590
591
Depreciation
463
526
512
518
568
666
759
806
892
980
1,123
1,201
1,257
PBT
1,159
1,255
1,580
2,763
1,661
7,416
634
1,682
2,740
830
554
-1,459
-1,709
Tax %
30%
20%
22%
2%
17%
3%
31%
16%
11%
46%
30%
18%
—
Net Profit
802
1,006
1,234
2,702
1,387
7,228
436
1,405
2,434
435
387
-1,715
-1,971
EPS in Rs
23.41
30.24
38.98
95.49
45.37
275
10.06
49.36
90.93
10.52
9.22
-74.41
-84.97
Div. Payout %
53%
33%
28%
23%
28%
4%
99%
25%
19%
143%
119%
-15%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
255
255
255
255
255
255
255
255
255
255
255
255
Reserves
5,297
6,600
7,653
10,847
12,086
12,643
14,035
17,998
19,466
21,986
21,339
20,951
Borrowings
8,379
9,090
7,072
6,108
6,130
7,702
6,933
7,025
6,296
5,563
7,072
8,001
Other Liabilities
6,872
8,402
8,607
8,648
8,398
7,073
7,115
8,566
8,923
8,907
9,084
9,791
Total Liabilities
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998
Fixed Assets
11,359
13,431
12,644
12,787
13,551
15,356
15,261
16,044
17,092
17,861
19,600
20,602
CWIP
189
350
333
409
774
835
1,094
1,667
2,410
2,217
1,913
1,038
Investments
443
2,188
2,787
2,840
5,615
4,285
5,816
7,683
7,448
9,739
9,144
9,886
Other Assets
8,811
8,377
7,822
9,822
6,929
7,198
6,167
8,449
7,990
6,894
7,093
7,472
Total Assets
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,274
2,332
3,531
1,870
1,581
1,780
2,037
1,644
2,971
3,016
1,761
1,269
Investing
-663
-463
-985
2,714
-1,927
-2,285
-1,147
-817
-1,149
-605
-1,667
-766
Financing
-1,087
-1,802
-2,341
-2,089
-1,712
-129
-1,456
-755
-2,076
-2,494
29
-670
Net Cash Flow
-477
68
205
2,494
-2,058
-634
-565
72
-254
-83
123
-167
Free Cash Flow
709
1,645
2,888
1,140
502
611
804
379
1,427
1,193
-191
129
CFO/OP
86
129
190
71
115
99
142
82
88
120
102
67
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73
88
74
46
51
56
50
56
57
45
47
52
Inventory Days
137
119
244
304
315
347
257
317
282
341
324
353
Days Payable
138
99
232
307
269
302
256
338
289
320
318
293
Cash Conversion Cycle
72
107
86
43
97
100
51
35
50
66
53
113
Working Capital Days
-4
31
-4
27
-2
-102
-28
-29
29
-22
-21
-17
ROCE %
11%
11%
10%
16%
9%
36%
4%
8%
12%
8%
4%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tata Chemicals insights

59 extracted metrics + investor summaries across FY14–FY27.

Log in — free

Shareholding Pattern

Public24.12%Govt.0.03%Promot.37.98%Others4.69%FIIs12.07%DIIs21.12%As ofJun 2026

Documents

Frequently Asked Questions about Tata Chemicals

What does Tata Chemicals Ltd do?
Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products [1]
Where is Tata Chemicals Ltd (TATACHEM) listed?
Tata Chemicals Ltd trades as TATACHEM on the NSE and under code 500770 on the BSE.
Which sector does Tata Chemicals Ltd belong to?
Tata Chemicals Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Tata Chemicals Ltd?
Tata Chemicals Ltd has a market capitalisation of ₹15,419 Cr, which places it in the Mid Cap band.
What is the PE ratio of Tata Chemicals Ltd?
Tata Chemicals Ltd trades at a PE ratio of -7.90, on earnings per share of ₹29.55, against a book value of ₹832.38 per share.
What is the 52-week high and low of Tata Chemicals Ltd?
Over the last 52 weeks Tata Chemicals Ltd has traded between ₹580.3 and ₹1,026.65.
Does Tata Chemicals Ltd pay dividends?
Tata Chemicals Ltd has a dividend yield of 1.80%.
What is the Return on Equity (ROE) of Tata Chemicals Ltd?
Tata Chemicals Ltd reported a return on equity of -7.73%. Its debt-to-equity ratio is 0.38.

Company Information

Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products [1]

Website tatachemicals.com
CEO Mr. Ramakrishnan Mukundan B.E.(Elec), MBA
Employees 4,789
Listed 1999-04-01
Face Value ₹ 10
Issued Size 25,47,56,278

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TATACHEM.md for Tata Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List